The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
105566362 10556636 2 F 20160711 20141031 20160715 EXP PHHY2014US139868 NOVARTIS MANCANO MA. GARCINIA CAMBOGIA-INDUCED ACUTE HEPATITIS VARENICLINE-INDUCED PARKINSONISM RESISTANT HYPOCALCEMIA AFTER ZOLEDRONIC ACID ADMINISTRATION ZONISAMIDE-INDUCED ACUTE KIDNEY INJURY PSYCHOSIS ASSOCIATED WITH GUANFACINE.. HOSPITAL PHARMACY. 2015;50 (7):564-8 73.00 YR F Y 0.00000 20160716 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
105566362 10556636 1 PS ZOMETA ZOLEDRONIC ACID 1 Unknown UNK UNK, ONCE/SINGLE 21223 1X
105566362 10556636 2 SS RECLAST ZOLEDRONIC ACID 1 Unknown UNK UNK, ONCE/SINGLE 0 1X
105566362 10556636 3 SS DEXAMETHASONE. DEXAMETHASONE 1 Unknown UNK UNK, QW 0 /wk
105566362 10556636 4 C VELCADE BORTEZOMIB 1 Unknown 3 DOSES 0
105566362 10556636 5 C REVLIMID LENALIDOMIDE 1 Unknown 7 DOSES 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
105566362 10556636 1 Plasma cell myeloma
105566362 10556636 2 Plasma cell myeloma
105566362 10556636 3 Plasma cell myeloma
105566362 10556636 4 Plasma cell myeloma
105566362 10556636 5 Plasma cell myeloma

Outcome of event

Event ID CASEID OUTC COD
105566362 10556636 HO
105566362 10556636 OT
105566362 10556636 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
105566362 10556636 Acute kidney injury
105566362 10556636 Blood creatinine increased
105566362 10556636 Cardiac arrest
105566362 10556636 Cardiomegaly
105566362 10556636 Depressed level of consciousness
105566362 10556636 Dizziness
105566362 10556636 Electrocardiogram QT prolonged
105566362 10556636 Febrile neutropenia
105566362 10556636 Generalised tonic-clonic seizure
105566362 10556636 Hypocalcaemia
105566362 10556636 Nausea
105566362 10556636 Oedema peripheral
105566362 10556636 Pancytopenia
105566362 10556636 Pulmonary oedema
105566362 10556636 Pyrexia
105566362 10556636 Rales
105566362 10556636 Respiratory distress
105566362 10556636 Vomiting
105566362 10556636 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found